T1	Haplotype	14 33	CYP3A5 * 3 carriers
T2	Pharmacodynamic_phenotype	63 97	rolimus dose requirements remained
T3	Disease	127 136	F , while
T4	Haplotype	140 159	CYP3A5 * 1 carriers
T5	Pharmacodynamic_phenotype	198 224	requirements were observed
R1	decreases	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	decreases	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	isAssociatedWith	Arg1:T2	Arg2:T3
R7	isAssociatedWith	Arg1:T2	Arg2:T4
R8	decreases	Arg1:T2	Arg2:T5
R9	treats	Arg1:T3	Arg2:T1
R10	decreases	Arg1:T3	Arg2:T2
R11	isAssociatedWith	Arg1:T3	Arg2:T4
R12	decreases	Arg1:T3	Arg2:T5
R13	isAssociatedWith	Arg1:T4	Arg2:T1
R14	decreases	Arg1:T4	Arg2:T2
R15	influences	Arg1:T4	Arg2:T3
R16	decreases	Arg1:T4	Arg2:T5
R17	isAssociatedWith	Arg1:T5	Arg2:T1
R18	isAssociatedWith	Arg1:T5	Arg2:T2
R19	isAssociatedWith	Arg1:T5	Arg2:T3
R20	isAssociatedWith	Arg1:T5	Arg2:T4
